Free Trial

Astera Labs (NASDAQ:ALAB) Shares Gap Down - What's Next?

Astera Labs logo with Computer and Technology background

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $133.30, but opened at $128.50. Astera Labs shares last traded at $121.89, with a volume of 863,679 shares traded.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of research analyst reports. Barclays raised their target price on Astera Labs from $87.00 to $135.00 and gave the stock an "overweight" rating in a research note on Friday. Roth Mkm lifted their price objective on Astera Labs from $80.00 to $105.00 and gave the company a "buy" rating in a research note on Tuesday, November 5th. Craig Hallum lifted their price objective on Astera Labs from $75.00 to $105.00 and gave the company a "buy" rating in a research note on Tuesday, November 5th. Northland Capmk lowered Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Thursday, January 2nd. Finally, Morgan Stanley lowered Astera Labs from an "overweight" rating to an "equal weight" rating and set a $142.00 price objective for the company. in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $109.75.

Check Out Our Latest Report on ALAB

Astera Labs Stock Down 6.7 %

The company has a 50 day moving average of $120.38 and a two-hundred day moving average of $77.29.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The firm had revenue of $113.10 million during the quarter, compared to analyst estimates of $97.50 million. The business's quarterly revenue was up 47.1% on a year-over-year basis. As a group, research analysts forecast that Astera Labs, Inc. will post -0.45 earnings per share for the current year.

Insiders Place Their Bets

In other Astera Labs news, insider Sanjay Gajendra sold 740,000 shares of the business's stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $96.59, for a total transaction of $71,476,600.00. Following the completion of the sale, the insider now directly owns 775,000 shares in the company, valued at approximately $74,857,250. The trade was a 48.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Stefan A. Dyckerhoff sold 50,000 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $89.70, for a total value of $4,485,000.00. Following the sale, the director now owns 129,617 shares of the company's stock, valued at approximately $11,626,644.90. This trade represents a 27.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,690,452 shares of company stock worth $167,581,256.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Hollencrest Capital Management acquired a new position in shares of Astera Labs during the 3rd quarter worth approximately $26,000. Geneos Wealth Management Inc. acquired a new position in shares of Astera Labs during the 4th quarter worth approximately $36,000. ORG Wealth Partners LLC acquired a new position in shares of Astera Labs during the 4th quarter worth approximately $42,000. US Bancorp DE acquired a new position in shares of Astera Labs during the 3rd quarter worth approximately $46,000. Finally, First Horizon Advisors Inc. acquired a new position in shares of Astera Labs during the 3rd quarter worth approximately $49,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Articles

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines